Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;28(9):1525-1533.
doi: 10.1158/1055-9965.EPI-18-1322. Epub 2019 Jun 11.

miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study

Loki Natarajan  1   2 , Minya Pu  2 , Sherri R Davies  3 , Tammi L Vickery  4 , Sandahl H Nelson  5 , Emily Pittman  2 , Barbara A Parker  2   6 , Matthew J Ellis  7 , Shirley W Flatt  2 , Elaine R Mardis  8 , Catherine R Marinac  9   10 , John P Pierce  5   2 , Karen Messer  5   2
Affiliations

miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study

Loki Natarajan et al. Cancer Epidemiol Biomarkers Prev. 2019 Sep.

Abstract

Background: There is substantial variation in breast cancer survival rates, even among patients with similar clinical and genomic profiles. New biomarkers are needed to improve risk stratification and inform treatment options. Our aim was to identify novel miRNAs associated with breast cancer survival and quantify their prognostic value after adjusting for established clinical factors and genomic markers.

Methods: Using the Women's Healthy Eating and Living (WHEL) breast cancer cohort with >15 years of follow-up and archived tumor specimens, we assayed PAM50 mRNAs and 25 miRNAs using the Nanostring nCounter platform.

Results: We obtained high-quality reads on 1,253 samples (75% of available specimens) and used an existing research-use algorithm to ascertain PAM50 subtypes and risk scores (ROR-PT). We identified miRNAs significantly associated with breast cancer outcomes and then tested these in independent TCGA samples. miRNAs that were also prognostic in TCGA samples were further evaluated in multiple regression Cox models. We also used penalized regression for unbiased discovery.

Conclusions: Two miRNAs, 210 and 29c, were associated with breast cancer outcomes in the WHEL and TCGA studies and further improved risk stratification within PAM50 risk groups: 10-year survival was 62% in the node-negative high miR-210-high ROR-PT group versus 75% in the low miR-210- high ROR-PT group. Similar results were obtained for miR-29c. We identified three additional miRNAs, 187-3p, 143-3p, and 205-5p, via penalized regression.

Impact: Our findings suggest that miRNAs might be prognostic for long-term breast cancer survival and might improve risk stratification. Further research to incorporate miRNAs into existing clinicogenomic signatures is needed.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Kaplan-Meier survival plots of miRNA*ROR-PT categories by nodal status: miRNA 210 (top), miRNA 29c (bottom)
See this image and copyright information in PMC

References

    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281–97. - PubMed
    1. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65(16):7065–70. - PubMed
    1. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2017;9(6):852. - PMC - PubMed
    1. Volinia S, Croce CM. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A 2013;110(18):7413–7. - PMC - PubMed
    1. van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 2015;17:21. - PMC - PubMed

Publication types